No Data
CENTOGENE NV | 6-K/A: Report of foreign private issuer (related to financial reporting)
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson's Disease in The Lancet Neurology
News On Centogene N.V. (CNTG) Now Under CNTGF
Centogene Receives Nasdaq Notice for Non-compliance
CENTOGENE Receives Delisting Notice From Nasdaq, Effective At The Open Of Trading On August 8, 2024
Express News | Centogene Shares Are Trading Lower. The Company Announced Data From It Rostock International Parkinson's Disease Study Revealing the Genetic Factors and Prevalence of Parkinson's Disease
No Data
No Data
